Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

New hair transplant methods offer more natural results and better graft survival, with ongoing research to increase donor hair options.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Many skin patients also have mental health issues, and doctors should treat both together.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Overweight women with PCOS are more likely to have excess male hormones.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

People undergoing chemotherapy need better support and information to cope with hair loss.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.